BT
Biosplice Therapeutics
CA - San Diego
BiotechnologyFocus: Small Molecules Acting on Stem Cells
Biosplice Therapeutics is a life sciences company focused on Small Molecules Acting on Stem Cells.
Cell Therapy
Open Jobs
0
Pipeline & Clinical Trials
Not applicable
OsteoarthritisClinical Trials (1)
NCT02951026An Observational Study Evaluating the Safety, Tolerability, and Efficacy of Treatment of SM04690 or Placebo Previously Injected in the Target Knee Joint of Subjects With Moderately to Severely Symptomatic Osteoarthritis
N/ASM08502
Solid Tumor, AdultClinical Trials (1)
NCT03355066A Study Evaluating the Safety and Pharmacokinetics of Orally Administered SM08502 in Subjects With Advanced Solid Tumors
Phase 1SM04755
TendinopathyClinical Trials (1)
NCT03502434A Repeat Insult Patch Test (RIPT) Study Evaluating the Sensitization Potential of Topical SM04755 Solution in Healthy Volunteers
Phase 1Phase 1
Clinical Trials (1)
NCT05084859A Study Evaluating the Safety, Pharmacokinetics, and Preliminary Efficacy of Orally Administered SM08502 Combined With Hormonal Therapy or Chemotherapy in Subjects With Advanced Solid Tumors
Phase 1SM04690, 0.03mg/2mL
Moderate to Severe OsteoarthritisClinical Trials (1)
NCT02095548Phase 1, Dose Escalation Study Evaluating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SM04690 in Moderate to Severe Knee Osteoarthritis (OA)
Phase 1SM04755
Colorectal CancerClinical Trials (1)
NCT02191761Safety and Pharmacokinetics of SM04755 in Subjects With Advanced Colorectal, Gastric, Hepatic, or Pancreatic Cancer
Phase 1SM04755
TendinopathyClinical Trials (1)
NCT03229291A Study Evaluating the Safety, Tolerability, and Pharmacokinetics of Multiple Ascending Doses of SM04755 Following Topical Administration to Healthy Subjects
Phase 1Lorecivivint
Drug-Drug InteractionClinical Trials (1)
NCT04598542Drug-Drug Interaction Study of Lorecivivint and Triamcinolone Acetonide in Healthy Volunteers
Phase 1SM04690
Degenerative Disc DiseaseClinical Trials (1)
NCT03246399A Study of the Safety, Tolerability, and Pharmacokinetics of SM04690 Injectable Suspension Following Single Intradiscal Injection in Subjects With Degenerative Disc Disease
Phase 1Cirtuvivint
Small-cell Lung CancerClinical Trials (1)
NCT07155200Small Cell Lung Cancer Irinotecan and CDC2-like Kinase Inhibition Trial (SLICK Trial)
Phase 1/2lorecivivint
Knee OsteoarthritisClinical Trials (1)
NCT03706521MRI Study to Evaluate the Safety and Efficacy of SM04690 for Knee Osteoarthritis
Phase 2Phase 2
Clinical Trials (1)
NCT03591926A Study Evaluating the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of SM04646 Inhalation Solution in Subjects With Idiopathic Pulmonary Fibrosis (IPF)
Phase 2Placebo
Knee OsteoarthritisClinical Trials (1)
NCT03727022Safety and Bone Health Study of SM04690 for the Treatment of Moderately to Severely Symptomatic Knee Osteoarthritis
Phase 2SM04554
Androgenetic AlopeciaClinical Trials (1)
NCT02275351A Study of the Safety, Tolerability, and Efficacy of Topical SM04554 Solution in Male Subjects With Androgenetic Alopecia (AGA)
Phase 2Cirtuvivint
Soft Tissue Sarcoma (STS)Clinical Trials (1)
NCT07032285Cirtuvivint in Selected Advanced Soft-Tissue Sarcomas
Phase 2SM04690
OsteoarthritisClinical Trials (1)
NCT02536833A Study Evaluating the Safety, Tolerability, and Efficacy of SM04690 Injected in the Target Knee Joint of Moderately to Severely Symptomatic Osteoarthritis Subjects
Phase 2SM04690
Knee OsteoarthritisClinical Trials (1)
NCT03122860A Study Evaluating the Safety and Efficacy of SM04690 for the Treatment of Moderately to Severely Symptomatic Knee Osteoarthritis
Phase 2Topical SM04554 solution
Androgenetic AlopeciaClinical Trials (1)
NCT02503137A Study of SM04554 Applied Topically to the Scalp of Male Subjects With Androgenetic Alopecia Analyzed by Biopsy of the Scalp Prior To and Post Dosing
Phase 2Topical SM04554 solution
Androgenetic AlopeciaClinical Trials (1)
NCT03742518A Study Evaluating the Efficacy and Safety of SM04554 Topical Solution in Male Subjects With Androgenetic Alopecia
Phase 2/3Lorecivivint
Osteoarthritis of the KneeClinical Trials (1)
NCT049316673-year, Open-Label Study Evaluating Safety, Tolerability, and Efficacy of Lorecivivint in Subjects With Osteoarthritis of the Knee
Phase 3Placebo
Osteoarthritis, KneeClinical Trials (1)
NCT04520607A Long-Term Safety and Efficacy Study of Lorecivivint in Subjects With Osteoarthritis of the Knee
Phase 3Lorecivivint
Knee OsteoarthritisClinical Trials (1)
NCT03928184Patient-Reported and Radiographic Outcomes in Evaluating Lorecivivint (SM04690) for the Treatment of Knee Osteoarthritis
Phase 3Lorecivivint
Knee OsteoarthritisClinical Trials (1)
NCT05603754A Study Utilizing Patient-Reported Outcomes to Evaluate the Safety and Efficacy of Lorecivivint (SM04690) for the Treatment of Moderately to Severely Symptomatic Knee Osteoarthritis (STRIDES)
Phase 3Lorecivivint
Knee OsteoarthritisClinical Trials (1)
NCT04385303Patient-Reported Outcomes in Evaluating Lorecivivint (SM04690) for Moderate to Severe Knee Osteoarthritis (STRIDES-1)
Phase 3Open Jobs (0)
No open positions listed yet. Check their careers page directly.
Interview Prep Quick Facts
Portfolio: 24 clinical trials